Drug information libraries on the internet

Journal of Psychoactive Drugs

Volumn 32, Issue 3, 2000, Pages 249-258

  Bogenschutz, Michael P ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Drug abuse; Drug usage; Hallucinogens; Internet

Indexed keywords

PSYCHOTROPIC AGENT;

INFORMATION SERVICE; INTERNET; REVIEW; STANDARD;

INFORMATION SERVICES; INTERNET; PSYCHOTROPIC DRUGS;

EID: 0034232246     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2000.10400447     Document Type: Article

References (53)

1. Abdei-Fattah, A.F; Matsumoto, K.; Gammaz, H.A. & Watanabe, H. 1995. Hypothermic effect of harmala alkaloid in rats: Involvement of serotonergic mechanism. Pharmacology, Biochemistry & Behavior 52 (2): 421-26.
2. Ahmed, A.G. & Salib, E. 1998. The khat users: A study of khat chewing in Liverpool's Somali men. Medicine, Science & the Law 38 (2): 165-69.
3. Alem, A. & Shibre, T. 1997. Khat induced psychosis and its medicolegal implication: A case report. Ethiopian Medical Journal 35 (2): 137-39.
4. Almeida, J.C. & Grimsley, E.W. 1996. Comafrom the health food store: Interaction between kava and alprazolam. Annals of Internal Medicine 125 (II): 940-41.
5. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, D.C.: American Psychiatric Association.
6. Callaway, J.C. & Grob, C.S. 1998. Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions. Journal of Psychoactive Drugs 30 (4): 367-69.
7. Cantor, C. 1997. Kava and alcohol. Medical Journal of Australia 167 (10): 560.
8. Cawte, J. 1985. Psychoactive substances of the South Seas: Betel, kava and pituri. Australian and New Zealand Journal of Psychiatry 19 (1): 83-87.
9. Centers for Disease Control and Prevention. 1996. Adverse events associated with ephedrine-containing products—Texas, December 1993-September 1995. Journal oftheAmerican MedicalAssociation 276 (21): 1711-12.
10. Chao, J.-M. & Der Marderosian, A.H. 1973. Ergoline alkaloidal constituents ofHawaiian baby woodrose, Argyreia nervosa (Burm. f.) Bojer. Journal of Pharmaceutical Sciences 62 (4): 588-91.
11. Chin, R.L.; Sporer, K.A.; Cullison, B.; Dyer, J.E. & Wu, T.D. 1998. Clinical course of gamma-hydroxybutyrate overdose. Annals of Emergency Medicine 31 (6): 716-22.
12. Cockings, J.G. & Brown, M. 1997. Ephedrine abuse causing acute myocardial infarction. Medical Journal of Australia 167 (4): 199-200.
13. Crosby, D M. & McLaughlin, J L. 1973. Cactus alkaloids XIX. Crystallization ofMescaline HCl and 3-Methoxytyramine HCl from Trichocereus pachanoi. Lloydia 36 (4): 416-18.
14. Dalgamo, PJ. & Shewan, D. 1996. Illicit use of ketamine in Scotland. Journal of Psychoactive Drugs 28 (2): 191-99.
15. Darboe, M.N. 1996. Abuse of dextromethorphan-based cough syrup as a substitute for licit and illicit drugs: A theoretical framework. Adolescence 31 (121): 239-45.
16. Darboe, M.N.; Keenan, G.R Jr.; & Richards, T.K. 1996. The abuse of dextromethorphan-based cough syrup: A pilot study of the community of Waynesboro, Pennsylvania. Adolescence 31(123): 633-44.
17. de Nesnera, A.P. 1996. Diphenhydramine dependence: A need for awareness. Journal of Clinical Psychiatry 57 (3): 136-37.
18. Dewitt, M.S.; Swain, R. & Gibson Jr., L.B. 1997. The dangers ofjimson weed and its abuse by teenagers in the Kanawha Valley of West Virginia. West Virginia Medical Journal 93 (4): 182-85.
19. Doyle, H. & Kargin, M. 1996. Herbal stimulant containing ephedrine has also caused psychosis. British Medical Journal 313 (7059): 756.
20. Ely, R.A. & McGarth, D.C. 1990. Lithium-ammonia reduction of ephedrine to methamphetamine: An unusual clandestine synthesis. Journal of Forensic Sciences 35 (3): 720-23.
21. Geisshusler, S. & Brenneisen, R. 1987. The content of psychoactive phenylpropyl and phenylpentenyl khatamines in Catha edulis Forsk. of different origin. Journal of Ethnopharmacology 19 (3): 269-77.
22. Giroud, C.; Augsburger, M.; Rivier, L.; Mangin, P.; Sadeghipour, F.; Varesio, E.; Veuthey, J.L. & Kamalaprija, P. 1998. 2C-B: A new psychoactive phenylethylamine recently discovered in ecstasy tablets sold on the Swiss black market. Journal of Analytical Toxicology 22 (5): 345-54.
23. Greene, G S.; Patterson, S.G. & Warner, E. 1996. Ingestion of angel’s trumpet: An increasingly common source of toxicity. Southern Medical Journal 89 (4): 65-69.
24. Grob, C.S.; McKenna, D.J.; Callaway, J.C., Brito, GS.; Oberlaender, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; Strassman, R.J. & Boone, K.B. 1996. Human psychopharmacology of hoasca: A plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disorders 184 (2): 86-94.
25. Haines, J.D. 1998. Absinthe—return of the green fairy. Journal— Oklahoma State Medical Association 91 (7): 406-07.
26. Hernandez, M.; McDaniel, C.H.; Costanza, CD. & Hernandez, O.J. 1998. GHB-induced delirium: A case report and review of the literature ofgamma hydroxybutyric acid. American Journal of Drug & Alcohol Abuse 24 (I): 179-83.
27. James, L.P.; Farrar, H.C.; Komoroski, E.M.; Wood, W.R.; Graham, C.J.; Bornemeier, R.A. & Valentine, J.L. 1998. Sympathomimetic drug use in adolescents presenting to a pediatric emergency department with chest pain. Journal of Toxicology —Clinical Toxicology 36 (4): 321-28.
28. Johnson, F.N.; Ary, I.E.; Teiger, D.G. & Kassel, R.J. 1973. Emetic activity of reduced lysergamides. Journal of Medicinal Chemistry 16 (5): 532-37.
29. Koevoets, P.F. & van Harten, P.N. 1997. Thorn apple poisoning. Nederlands Tijdschrift voor Geneeskunde 141 (18): 888-89.
30. Li, J., Stokes, S.A. & Woeckener, A. 1998. A tale of novel intoxication: Seven cases of gamma-hydroxybutyric acid overdose. Annals of Emergency Medicine 31 (6): 723-28.
31. Lowinson, J. H. (Ed.) 1997. Substance Abuse: A Comprehensive Textbook, Third Ed. Baltimore, Maryland: Williams & Wilkins.
32. Marvel, C.S. & Birkhimer, E.R. 1929. The preparation of the sodium salts of omega-hydroxybutyric, -valeric, and -caproic acids. Journal of the American Chemical Society 51: 260-62.
33. McKenna, D.J. & Towers, G.H. 1984. Biochemistry and pharmacology of tryptamines and beta-carbolines: A minireview. Journal of Psychoactive Drugs 16 (4): 347-58.
34. Nordt, S.P 1998. “DXM”: A new drug of abuse? Annals of Emergency Medicine 31 (6): 794-95.
35. Ott, J. 1995. The Age ofEntheogens & theAngel's Dictionary. Kennewick, Washington: Natural Products Co.
36. Ott, J. 1993. Pharmacotheon: Entheogenic Drugs, Their Plant Sources and Histories. Kennewick, Washington: Natural Products Co.
37. Perlik-Gattner, I. 1997. Atropa belladonna poisoning suggesting severe post-traumatic brain damage. Przeglad Lekarski 54 (6): 464-65.
38. Polles, A. & Griffith, J.L. 1996. Dextromethorphan-induced mania. Psychosomatics 37 (1): 71-74.
39. Powell, T.; Hsu, F.F.; Turk, J. & Hruska, K. 1998. Ma-huang strikes again: Ephedrine nephrolithiasis. American Journal of Kidney Diseases 32 (I): 153-59.
40. Rowe, C.; Verjee, Z. & Koren, G. 1997. Adolescent dimenhydrinate abuse: Resurgence of an old problem. Journal of Adolescent Health 21 (1): 47-9.
41. Saunders, N. 1993. Efor Ecstasy. London: Nicholas Saunders.
42. Schultes, R E. & Hofmann, A. 1992. Plants of the Gods: Their Sacred. Healing, and Hallucinogenic Powers. Rochester, Vermont: Healing Arts Press.
43. Selassie, S.G. & Gebre, A. 1996. Rapid assessment of drug abuse in Ethiopia. Bulletin on Narcotics 48 (1-2): 53-63.
44. Sheppard, S.G. 1994. A preliminary investigation of ibogaine: Case reports and recommendations for further study. Journal of Substance Abuse Treatment II (4): 379-85.
45. Shulgin, A. & Shulgin, A. 1991. PIHKAL: A Chemical Love Story. Berkeley, California: Transform Press.
46. Siebert, D.J. 1994. Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology 43 (I): 53-56.
47. Sjoholm, A.; Lindberg, A. & Personne, M. 1998. Acute nutmeg intoxication. Journal of Internal Medicine 243 (4): 329-31.
48. Spillane, P.K.; Fisher, D.A. & Currie B.J. 1997. Neurological manifestations of kava intoxication. Medical Journal of Australia 167 (3): 172-73.
49. Takahara, J; Yunoki, S.; Yakushiji, W., Yamauchi, J.; Yamane, J. & Ofuji, T. 1977. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. Journal of Clinical Endocrinology and Metabolism 44 (5): 1014-17.
50. Theoharides, T.C. 1997. Sudden death of a healthy college student related to ephedrine toxicity from a rna huang-containing drink. Journal of Clinical Psychopharmacology 17(5): 437-39.
51. Tiongson, J. & Salen P. 1998. Mass ingestion ofjimson weed by eleven teenagers. Delaware Medical Journal 70 (11): 471-76.
52. White, L.M.; Gardner, S.F.; Gurley, B.J.; Marx, M.A.; Wang, P.L. & Estes, M. 1997. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. Journal of Clinical Pharmacology 37 (2): 116-22.
53. Weil, AT. & Davis, W. 1994. Bufo alvarius: A potent hallucinogen of animal origin. Journal of Ethnopharmacology 41 (1-2): 1-8.